Kalu A, Ray S
Brain Sci. 2025; 15(2).
PMID: 40002477
PMC: 11853474.
DOI: 10.3390/brainsci15020144.
Cooley Coleman J, Moffitt B, Bridges W, Jones K, May M, Skinner C
Metab Brain Dis. 2025; 40(2):124.
PMID: 39945871
PMC: 11825590.
DOI: 10.1007/s11011-025-01546-5.
Olaitan G, Ganesana M, Strohman A, Lynch W, Legon W, Venton B
J Neurochem. 2025; 169(2):e70001.
PMID: 39902479
PMC: 11791541.
DOI: 10.1111/jnc.70001.
Manchado A, Garcia-Gonzalez A, Nieto C, Diez D, Garrido N
Molecules. 2024; 29(23).
PMID: 39683888
PMC: 11643920.
DOI: 10.3390/molecules29235729.
Feng J, Zhao J, Kuang Y, Zhou Y, Ye Z, He Y
Heliyon. 2024; 10(23):e39830.
PMID: 39654770
PMC: 11626004.
DOI: 10.1016/j.heliyon.2024.e39830.
Dysregulation of protein degradation and alteration of secretome in α-synuclein-exposed astrocytes: implications for dopaminergic neuronal dysfunction.
Raj A, Banerjee R, Holla V, Kamble N, Yadav R, Pal P
Cell Commun Signal. 2024; 22(1):574.
PMID: 39617881
PMC: 11610152.
DOI: 10.1186/s12964-024-01928-9.
Human-Brain-Derived Ischemia-Induced Stem Cell Transplantation Is Associated with a Greater Neurological Functional Improvement Compared with Human-Bone Marrow-Derived Mesenchymal Stem Cell Transplantation in Mice After Stroke.
Tanada S, Nakagomi T, Nakano-Doi A, Sawano T, Kubo S, Kuramoto Y
Int J Mol Sci. 2024; 25(22).
PMID: 39596134
PMC: 11593343.
DOI: 10.3390/ijms252212065.
De novo missense variant in a patient with Parkinson's disease.
Alluqmani M, Alayoubi A, Hashmi J, Basit S
Front Genet. 2024; 15:1496683.
PMID: 39568674
PMC: 11576416.
DOI: 10.3389/fgene.2024.1496683.
Mendelian randomisation analysis to explore the association between cathepsins and bipolar disorder.
Dong C, Han Y, Chen S, Wang G
BMC Psychiatry. 2024; 24(1):758.
PMID: 39482620
PMC: 11529291.
DOI: 10.1186/s12888-024-06210-3.
Potential Neuroprotective Effects of (Galangal): A Review.
Abd Rahman I, Adam S, A Hamid A, Mokhtar M, Mustafar R, Kashim M
Nutrients. 2024; 16(19).
PMID: 39408345
PMC: 11478918.
DOI: 10.3390/nu16193378.
Intercellular transmission of alpha-synuclein.
Wu S, Schekman R
Front Mol Neurosci. 2024; 17:1470171.
PMID: 39324117
PMC: 11422390.
DOI: 10.3389/fnmol.2024.1470171.
Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders.
Ijomone O, Oria R, Ijomone O, Aschner M, Bornhorst J
Mol Neurobiol. 2024; 62(2):2420-2434.
PMID: 39110391
PMC: 11772124.
DOI: 10.1007/s12035-024-04418-8.
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.
Currim F, Tanwar R, Brown-Leung J, Paranjape N, Liu J, Sanders L
Neurotoxicology. 2024; 103:266-287.
PMID: 38964509
PMC: 11288778.
DOI: 10.1016/j.neuro.2024.06.016.
mTOR pathway inhibition alters proliferation as well as differentiation of neural stem cells.
Romanyuk N, Sintakova K, Arzhanov I, Horak M, Gandhi C, Jhanwar-Uniyal M
Front Cell Neurosci. 2024; 18:1298182.
PMID: 38812794
PMC: 11133533.
DOI: 10.3389/fncel.2024.1298182.
Dopamine Pharmacodynamics: New Insights.
Lauretani F, Giallauria F, Testa C, Zinni C, Lorenzi B, Zucchini I
Int J Mol Sci. 2024; 25(10).
PMID: 38791331
PMC: 11121567.
DOI: 10.3390/ijms25105293.
Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function.
Wadsworth H, Warnecke A, Barlow J, Robinson J, Steimle E, Ronstrom J
Cell Biosci. 2024; 14(1):50.
PMID: 38632622
PMC: 11025261.
DOI: 10.1186/s13578-024-01228-2.
Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia.
van der Pluijm M, Wengler K, Reijers P, Cassidy C, Tjong Tjin Joe K, de Peuter O
Am J Psychiatry. 2024; 181(6):512-519.
PMID: 38476044
PMC: 11227872.
DOI: 10.1176/appi.ajp.20220780.
Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.
Jhanwar-Uniyal M, Zeller S, Spirollari E, Das M, Hanft S, Gandhi C
Cells. 2024; 13(5.
PMID: 38474373
PMC: 10930964.
DOI: 10.3390/cells13050409.
Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges.
Watanabe H, Dijkstra J, Nagatsu T
Int J Mol Sci. 2024; 25(4).
PMID: 38396687
PMC: 10888576.
DOI: 10.3390/ijms25042009.
Potential Therapeutic Approach using Aromatic l-amino Acid Decarboxylase and Glial-derived Neurotrophic Factor Therapy Targeting Putamen in Parkinson's Disease.
Tripathi R, Goyal L, Singh S
Curr Gene Ther. 2024; 24(4):278-291.
PMID: 38310455
DOI: 10.2174/0115665232283842240102073002.